We are live on ! Find out more
OCRX

Ocera Therapeutics, Inc.
OCRX

Delisted

OCRX was delisted on the 8th of December, 2017.

Back to rankings

29 hedge funds and large institutions have $22.4M invested in Ocera Therapeutics, Inc. in 2015 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

67% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 6

7% more funds holding

Funds holding: 27 → 29 (+2)

4% more capital invested

Capital invested by funds: $21.5M → $22.4M (+$914K)

Holders
29
Holders Change
+2
Holders Change %
+7.41%
% of All Funds
0.76%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
10
Reduced
6
Closed
2
Calls
$50K
Puts
–
Net Calls
+$50K
Net Calls Change
+$50K

Top Buyers

Rank Fund Capital Flow
1
QF
QVT Financial
New York
+$613K
2
TI
Turner Investments
Pennsylvania
+$520K
3
SFM
Sphera Funds Management
Israel
+$171K
4
Renaissance Technologies
Renaissance Technologies
New York
+$160K
5
Citadel Advisors
Citadel Advisors
Florida
+$64.7K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$141K
2
ECM
Endurant Capital Management
California
-$137K
3
NI
Numeric Investors
Massachusetts
-$59K
4
Millennium Management
Millennium Management
New York
-$52.1K
5
Deutsche Bank
Deutsche Bank
Germany
-$35.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
GPP
1
Great Point Partners
Connecticut
$6.13M – – –
QF
2
QVT Financial
New York
$2.91M +$613K +179,508 +24%
VM
3
VHCP Management
New York
$2.2M – – –
TI
4
Turner Investments
Pennsylvania
$2.1M +$520K +152,210 +29%
SFM
5
Sphera Funds Management
Israel
$1.72M +$171K +50,000 +10%
Millennium Management
6
Millennium Management
New York
$1.67M -$52.1K -15,251 -3%
SM
7
Sabby Management
Florida
$1.2M -$141K -41,244 -10%
Vanguard Group
8
Vanguard Group
Pennsylvania
$1.19M +$44.1K +12,903 +4%
WMSA
9
Weiss Multi-Strategy Advisers
New York
$615K -$1.47K -429 -0.2%
ECM
10
Endurant Capital Management
California
$428K -$137K -40,028 -23%
PVI
11
Pura Vida Investments
New York
$409K – – –
GTC
12
Ghost Tree Capital
New York
$390K – – –
Renaissance Technologies
13
Renaissance Technologies
New York
$328K +$160K +46,900 +81%
BCM
14
Bridgeway Capital Management
Texas
$259K – – –
Geode Capital Management
15
Geode Capital Management
Massachusetts
$189K +$615 +180 +0.3%
Bank of New York Mellon
16
Bank of New York Mellon
New York
$119K +$12.9K +3,774 +11%
BFA
17
BlackRock Fund Advisors
California
$111K +$3.61K +1,056 +3%
Stifel Financial
18
Stifel Financial
Missouri
$103K -$6.83K -2,000 -6%
California Public Employees Retirement System
19
California Public Employees Retirement System
California
$96K – – –
Citadel Advisors
20
Citadel Advisors
Florida
$59K +$64.7K +18,932 New
Dimensional Fund Advisors
21
Dimensional Fund Advisors
Texas
$49K +$10.6K +3,107 +25%
QSS
22
Quantitative Systematic Strategies
Florida
$42K +$46.3K +13,548 New
Northern Trust
23
Northern Trust
Illinois
$40K – – –
GT
24
Glenmede Trust
Pennsylvania
$35K – – –
Group One Trading
25
Group One Trading
Illinois
$17K +$18.8K +5,500 New
1
2

OCRX Hedge Fund Activity: Q4 2015 in Review

29 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Ocera Therapeutics, Inc. (OCRX) for Q4 2015, worth a combined $22.4M — up 4.3% from $21.5M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new OCRX positions and 2 closed out — a net gain of 2 holders — while 10 added to existing stakes and 6 trimmed.

The largest buyer was QVT Financial, adding an estimated $613K. The largest seller was Sabby Management, cutting an estimated $141K.

  • 29 institutional investors held Ocera Therapeutics, Inc. (OCRX) as of Q4 2015, up from 27 in Q3 2015.
  • Funds reported $22.4M of Ocera Therapeutics, Inc. stock for Q4 2015, up 4.3% quarter-over-quarter.
  • 4 funds opened new Ocera Therapeutics, Inc. positions in Q4 2015 and 2 closed out, a net change of +2 holders.
  • The largest Ocera Therapeutics, Inc. buyer in Q4 2015 was QVT Financial, an estimated $613K added.
  • The largest Ocera Therapeutics, Inc. seller in Q4 2015 was Sabby Management, an estimated $141K sold.

Based on aggregated 13F filings for Q4 2015.